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onstrated synechiae and one a “tip” lesion. The interstitium
showed only minimal fibrosis with scattered small numbers of
chronic inflammatory cells. Ultrastructural studies sampled 7
intact glomeruli, 3 of which showed segmental sclerosis. No
electron-dense deposits were seen, and immunofluorescence
demonstrated only trace epithelial staining for albumin.
The patient was initially treated with prednisone, 60 mg/day,
for 12 weeks. Proteinuria increased from approximately 5 g/day
to 12 g/day. The patient subsequently received cyclosporine.
The proteinuria declined to 1.5 g/day during the first 6-month
course of cyclosporine but rose to approximately 3 g/day after
cyclosporine was discontinued. Proteinuria declined to 1 g/day
during a second 6-month course of cyclosporine but rose to 5
g/day after the drug was discontinued. The proteinuria declined
to 2 g/day during a subsequent one-year course of cyclosporine
but then rose to 4 g/day while the patient was still taking theCASE PRESENTATION
drug. During that time, his serum creatinine rose from 1.2
A 40-year-old man was admitted to the hospital for a renal mg/dL to 1.6 mg/dL. The patient continued taking an ACE
biopsy; three years earlier his first renal biopsy had revealed inhibitor, but his blood pressure became harder to control.
focal segmental glomerulosclerosis. Proteinuria first had been A second renal biopsy, the focus of our discussion today,
noted on a routine physical examination at approximately age was performed. Light microscopy disclosed 13 glomeruli, of
20. The proteinuria, initially in the subnephrotic range, was which 2 showed global sclerosis and 2 showed segmental sclero-
not accompanied by notable activity of the urinary sediment. sis. The interstitium demonstrated focal interstitial fibrosis as-
Around the age of 30, the patient developed hypertension and sociated with a mild chronic inflammatory infiltrate. Tubular
hypercholesterolemia, which were treated with an angiotensin- atrophy was noted. Ultrastructural studies revealed extensive
converting-enzyme (ACE) inhibitor and a statin, respectively. foot process effacement in one glomerulus and normal epithe-
Serial urinalyses by his personal physician revealed persistent lial structure in another. Again, no electron-dense deposits
subnephrotic proteinuria. By age 37, however, the urinary pro- were noted and immunofluorescence demonstrated only weak
tein excretion had increased to 4 g/day and the serum albumin staining for C3 and IgM in the mesangium of sclerosed glo-
had fallen to 3.4 g/dL. The serum creatinine level remained meruli.
normal at 1.0 mg/dL.
Further workup to determine the cause of proteinuric renal
disease was initiated. The patient had no history of childhood DISCUSSION
renal disease or other urinary tract disease. He had no history of
Dr. Timothy W. Meyer (Chief, Section of Nephrology,drug use, and serologic studies for autoimmune and infectious
VA Palo Alto Health Care System, and Professor of Medi-diseases associated with nephrotic-range proteinuria were neg-
ative. cine, Stanford University, Palo Alto, California, USA):
The initial renal biopsy disclosed 16 glomeruli on light mi- This patient’s second renal biopsy showed changes typi-
croscopy, five of which had global sclerosis and one segmental cal of proteinuric glomerular disease advancing to renal
sclerosis. Another glomerulus showed periglomerular fibrosis insufficiency. The diagnosis of focal segmental glomeru-and wrinkling, consistent with ischemia. Several glomeruli dem-
losclerosis was based on the finding of segmental sclerotic
lesions in 2 of 13 glomerular profiles. In addition, 2 glo-
meruli were globally sclerosed, and 2 appeared shrunkenThe Nephrology Forum is funded in part by grants from Amgen,
Incorporated; Merck & Co., Incorporated; Dialysis Clinic, Incorpo- and collapsed with wrinkling of the basement mem-
rated; and Bristol-Myers Squibb Company. branes. Glomerular injury was accompanied by tubulo-
interstitial injury. Some tubular segments were hypertro-Key words: proteinuria, tubular atrophy, interstitial fibrosis, tubulo-
interstitial disease, renal failure, fibrogenic cytokines. phic, but many were atrophic. Some were filled with
protein casts. The interstitium was expanded, especially 2003 by the International Society of Nephrology
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around the most damaged tubules, and contained a tion studies, and he thought they might continue to func-
tion like the tubules in the then-recently-describedpatchy mononuclear cell infiltrate.
aglomerular fishes. But subsequent functional studies
Intact nephron hypothesis have shown that significant tubular function does not
persist without glomerular function in patients with renalHow are these changes in glomerular, tubular, and
interstitial structure related? The organization of glo- disease [1].
meruli and tubules into individual nephrons cannot be
Contribution of tubular injury to loss of renal functionappreciated on examination of routinely prepared tissue
sections. But physiologic studies have suggested that When we see a damaged glomerulus attached to an
atrophic tubule, has glomerular injury caused tubulareven when disease causes structural changes like those
seen in this biopsy specimen, glomerular and tubular injury, has tubular injury caused glomerular injury, or
both? The answer might be different for individual neph-function remain closely integrated. Evidence that glo-
merular and tubular function remain linked in diseased rons as well as for individual patients. In today’s patient,
a biopsy was first performed more than 10 years afterkidneys can be usefully summarized by the term “intact
nephron hypothesis,” as originally proposed by Neal renal disease was detected. We cannot exclude the possi-
bility that focal glomerulosclerosis developed in responseBricker in 1960 [1]. This hypothesis does not imply that
each nephron is either untouched by disease or obliter- to an antecedent tubular or interstitial injury, but we do
have strong evidence that once established, proteinuricated. Rather, the initial population of homogeneous
nephrons is replaced by a lesser population in which glomerular injury can cause tubular injury [10–16]. The
question then becomes, to what extent does tubular in-neighboring structures exhibit heterogeneous patterns
of form and function. jury contribute to loss of nephron function? In some
nephrons, the tubule might atrophy only when glomeru-Important support for the intact nephron hypothesis
was provided by micropuncture studies by Carl Gottschalk lar injury lowers the single-nephron GFR. In others,
proteinuric glomerular injury could cause tubular injuryand colleagues in the 1970s [2–4]. These studies showed
that in rats with chronic glomerulonephritis, glomerular by means other than reduction in filtration, and this
secondary tubular injury then might cause loss of func-filtration rate (GFR) for single nephrons varied from
one-third to three times normal. Yet the fraction of so- tion while the glomerulus is still perfused and part of its
surface remains available for filtration. To the extentdium and water reabsorbed was the same in proximal
tubules connected to hypofiltering and hyperfiltering glo- that this is the case, treatment to limit tubular injury
could slow the loss of renal function even when glomeru-meruli. Similar results were obtained in rats with tubular
disease caused by heavy metals. Filtration was markedly lar injury cannot be prevented.
Early studies that analyzed renal biopsy specimens arereduced in glomeruli attached to the most severely dam-
aged tubules, but the balance between glomerular filtra- often said to have established that tubular and interstitial
injury are the major contributors to loss of renal function,tion and proximal fluid reabsorption was maintained.
The mechanisms that keep glomerular and tubular even in primary glomerular diseases [17–19]. These stud-
ies found that renal function is better correlated withfunction linked as renal disease progresses are not fully
understood. Tubuloglomerular feedback might reduce scores for tubular atrophy and interstitial expansion than
with scores for glomerular injury. Their results have stim-single-nephron GFR when damaged tubules fail to re-
absorb a normal amount of filtrate, and changes in peritu- ulated a great deal of valuable work. But the correlations
of function and structure originally reported did not inbular Starling forces might limit proximal reabsorption
when filtration is reduced in damaged glomeruli. Ulti- fact provide conclusive evidence that tubular injury is
more often the proximate cause of nephron loss than ismately, these functional changes are associated with
structural changes. If the flow of filtrate is stopped, tu- glomerular injury. One problem has been unequal sam-
pling of glomeruli and tubules. Glomerular injury has beenbules atrophy [5]. If tubules are injured, upstream glo-
meruli shrink and can become sclerotic [3, 6–8]. More scored by examination of as few as 10 profiles, while
tubular injury has usually been assessed by examinationthan 60 years ago, Jean Oliver used serial histologic
sections to reconstruct individual nephrons from patients of a larger sample. A potentially greater problem has
been posed by the semiquantitative methods used todying with renal failure. He demonstrated that the kid-
neys of these patients contained large glomeruli con- assess glomerular injury. The structural features on which
injury scores have been based might not accurately re-nected to hypertrophic tubules and shrunken glomeruli
connected to atrophic tubules (Fig. 1) [9]. Oliver also flect filtration capacity. A particular problem is that glo-
merular size and capillary surface area usually have notmicrodissected individual nephrons from diseased kid-
neys. Of note, he was not convinced that tubular atrophy been measured. When more detailed morphometric mea-
surements have been made, GFR has been correlatedand glomerular atrophy were invariably associated. He
identified some aglomerular tubules in his microdissec- with changes in glomerular structure [20, 21]. Overall, it
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Fig. 1. Individual nephron units in the kidney of a patient dying with “hemorrhagic Bright’s disease.” The patient was a physician who provided
Addis and Oliver (case xv [10]) with a detailed account of his 11-year course of nephritis attributed to streptococcal infection. Progressive decline
of renal function to 10% of normal over the last 6 years was documented with Addis’ then new urea ratio test. The upper panel provides a
general view of the renal cortex showing the situation of a hypertrophic nephron (A ) and an atrophic nephron (B ) that were selected for further
analysis (28). Serial sections were made though these selected areas at 5  intervals and wax reconstructions of the individual nephrons were
prepared from the serial sections as illustrated by the figures in the lower panel. The micrograph labeled (C ) is from the section passing through
the center of the atrophic nephron (100) and (D ) is a picture of the wax reconstruction of this nephron. (E ) and (F ) provide similar illustrations
of the hypertrophic nephron. (Reproduced from [9] with permission.)
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seems likely that tubular and glomerular structure function was due entirely to tubular injury. But this was
not the case in our studies of proteinuric glomerularchange together, as originally suggested by Bricker [1]
and Gottschalk [2]. Analysis of biopsies has emphasized disease. In these studies, many atubular glomeruli also
exhibited segmental sclerotic injury [22, 23]. Thus, thethat tubules can be injured and renal function lost when
glomeruli are not globally sclerosed. But further study extent to which prevention of tubular injury would have
preserved function was not clear. Moreover, the findingis required to determine the extent to which tubular
injury per se contributes to loss of function. of atubular glomeruli does not identify the cause of tubu-
lar atrophy. Marcussen and coworkers also found atubu-We could better estimate the extent to which tubular
injury causes loss of function if we could identify glomer- lar glomeruli in ischemic renal injury [7]. It is possibly
relevant to the current case that we have observed aular structural changes that are caused by tubular injury.
The use of serial sectioning to examine glomeruli and subpopulation of glomeruli with reduced volume in rats
with renal insufficiency caused by chronic cyclosporinetubules of individual nephrons provides one means of
doing this. The serial sectioning technique was first ap- administration [25]. Serial sections were not made, but
these glomeruli looked like those found to be atubularplied by Marcussen to analyze structural changes respon-
sible for loss of renal function in rats with nephrotoxic in other studies. Thus, overall, the serial section tech-
nique has confirmed that glomerular structure does notinjury [6]. Remarkably, Marcussen and colleagues found
large numbers of shrunken “atubular” glomeruli with remain normal as tubules atrophy. It also has provided
improved quantitation of the extent of tubular loss. Butopen capillary loops but no attached tubules in rats with
renal insufficiency caused by cis platinum and by lithium morphologic criteria for determining the cause of tubular
loss have not yet been developed, and we cannot cur-[6–8]. Other glomeruli with similar appearance were
attached only to atrophic structures representing the ves- rently tell whether tubular injury is due to ischemia,
obstruction, protein leakage from the glomerulus, ortiges of normal tubular segments. The reduction in GFR
closely correlated with the fraction of glomeruli that other causes.
Finally, I should note that serial sectioning has beenwere either atubular or attached to vestigial tubules.
We applied the serial section technique to examine carried out mostly in rat models, and we do not know
how the appearance of atubular glomeruli might changedisease progression in experimental glomerular disease.
An initial study examined renal structure at 10 and 25 over the long course of human renal disease. Despite
these caveats, serial sectioning might provide an indexweeks after five-sixths renal ablation [22]. As expected,
renal ablation induced hypertension and progressive glo- of the contribution of tubular injury to loss of renal func-
tion. In the patient described today, a separate biopsymerular injury manifested by heavy proteinuria. By 25
weeks, remnant kidney GFR had decreased to approxi- core was embedded in Epon and serially sectioned at 3
micron intervals. A total of 16 glomeruli were examined,mately 25% of the value seen at 10 weeks. Examination
of serial sections revealed that this decrease in renal of which 4 were globally sclerotic, 2 were atubular, and
4 were connected to vestigial tubules (Fig. 2). Only 6function was associated with an increase in the percent-
age of glomeruli no longer connected to normal tubules. glomeruli remained connected to normal-appearing tu-
bules. The volume of these 6 glomeruli averaged 8.8 At 10 weeks, an average of 20% of glomeruli were atubu-
lar or connected only to vestigial tubules, while at 25 1.7 (SD) 106 3, a value much greater than the average
value of 2.6  0.8  106 3 obtained using the sameweeks this portion had increased to approximately 75%.
Of note, the prevalence of glomeruli no longer connected method in normal subjects [21]. In contrast, the volume
of glomeruli that were atubular or connected only toto normal tubules greatly exceeded the prevalence of
glomeruli that were globally sclerosed. In a subsequent vestigial tubules averaged only 2.0 1.0 106 3, similar
to the value of 1.7  0.5  106 3 obtained in globallystudy that examined glomerular and tubular injury in
rats with adriamycin nephrosis, we found that GFR fell sclerotic glomeruli. These results are consistent with the
hypothesis that tubular injury contributed significantlyto approximately 20% of normal after 16 weeks of ne-
phrosis [23]. The reduction in GFR again closely corre- to nephron loss in this case while hypertrophy of remnant
functioning nephrons limited the reduction in GFR.lated with the appearance of glomeruli that were atubu-
lar or connected only to vestigial tubules. Most recently, Clearly, further studies are required to assess the contri-
bution of tubular injury to the progression of humanwe have found that some glomeruli become atubular
during even a brief episode of acute puromycin nephrosis glomerular disease.
[24].
Potential mechanisms of tubular cell injuryLimitations in the interpretation of serial sections must
be acknowledged. In the models of toxic injury studied Acknowledging that the extent to which tubular injury
contributes to the progression of glomerular disease hasby Marcussen and colleagues [6–8], atubular glomeruli
were reduced in size but otherwise appeared normal. not been fully established, we pass on to the question of
how tubules are injured. The processes responsible forIt could reasonably be presumed that loss of nephron
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Fig. 2. Glomerular profiles from the patient described in this Forum. The glomerulus in (A ) retains a connection to a proximal tubule segment
that appears normal (arrow). In contrast, the glomerulus in (B ) is connected to a markedly atrophic tubular segment (arrow). Tubular atrophy
in this case did not appear to be associated with a tuft adhesion. Serial sections revealed that the glomerulus in (C ) did not have any tubular
connection. This glomerulus has a cystic appearance that is only occasionally seen in atubular glomeruli in experimental studies (toluidine blue,
180).
Table 1. Potential mechanisms of tubular injury
Obstruction of tubular lumen by casts
Obliteration of tubular neck by glomerular tuft adhesions
Effects of filtered macromolecules on tubular cells
Actions of proteins with specific tubular receptors (growth factors,
etc.)
Results of “excessive” endocytosis of filtered plasma proteins
Toxic effects of molecules bound to plasma proteins (lipids, etc.)
Toxic effects of heme
tubular injury of course might differ in different cases.
At present, we can only compile a list of potential mecha-
nisms of injury (Table 1). One simple but often-neglected
mechanism is luminal obstruction. Dilated tubular seg-
Fig. 3. Effect of single-nephron obstruction for five weeks. The distal
ments with flattened epithelial cells and lumina filled tubule of a superficial glomerulus in a Munich-Wistar rat was occluded
by microinjection of silicon rubber. A remnant of the obstructingwith protein casts are commonly seen in diseases charac-
“cast,” which shrank during tissue processing, is visible within a dilatedterized by heavy proteinuria, especially in animal mod-
tubule profile (wide arrow). The glomerulus belonging to the ob-
els. The potential contribution of cast formation to tubu- structed tubule appears collapsed and retains only a vestigial connec-
tion to an atrophic proximal tubule (arrowhead). Several profiles oflointerstitial disease was pointed out by Bertani et al in
the proximal tubule appear as nests of epithelial cells without visibletheir original description of chronic adriamycin nephro-
lumina (thin arrows). A normal glomerulus and proximal tubules are
sis [26, 27]. That luminal obstruction causes atubular seen to the left of the picture. These findings largely replicate the work
of Tanner and Evan [5], except that the obstruction here was in theatrophy was elegantly demonstrated by Tanner and Evan
distal tubule rather than the proximal tubule. (From Pagtalunan, Olson,[5, 28], who showed that chronic obstruction of single
and Meyer, unpublished observations.)
proximal tubules led to atrophy of both upstream and
downstream segments. The latter result suggests that tub-
ules atrophy when delivery of filtrate is reduced for any
reason. Glomeruli of obstructed tubules eventually shrink to limit cast formation in rats with adriamycin nephrosis
by decreasing urine concentration with a vasopressin V2and appear collapsed. Indeed, as Figure 3 illustrates, such
glomeruli have the same appearance as the atubular glo- receptor blocker [23]. This maneuver had no effect on cast
formation or any other aspect of renal injury, however.meruli seen by Marcussen and coworkers in models of
toxic tubular injury [6–8]. The extent to which cast forma- Kriz and colleagues described another mechanism by
which glomerular injury can cause tubular loss beforetion causes tubular loss in glomerular disease will be-
come clear only when cast formation can be prevented. glomeruli are completely sclerosed [29, 30]. They exam-
ined the relation of tubular and glomerular structureSo far, this has not been accomplished. We recently tried
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in experimental models of heavy proteinuria in which predominate in commonly studied rodent models of glo-
merular disease might not be the same as those operatingpodocyte injury induced adhesion of the tuft to Bow-
man’s capsule. Adhesion formation was followed by ac- in more slowly progressive human disease.
Currently, the most widely proposed cause of tubularcumulation of amorphous material in a paraglomerular
space that sometimes extended along the capsule to sur- injury in glomerular disease is excessive tubular uptake
of filtered proteins or protein-bound substances [10–16].round the neck of the tubule. Tracer studies indicated
that the amorphous material included plasma proteins According to this hypothesis, injury begins in the proxi-
mal tubule, where filtered proteins are endocytosed. In-delivered to the paraglomerular space by “misdirected”
filtration from glomerular capillary loops adherent to the jury then extends downstream and is multiplied by sec-
ondary processes of inflammation and fibrosis. Studiescapsule [31]. Tubular degeneration was observed where
the material extended down the tubule, separating the showing that the rate of disease progression correlates
with the amount of proteinuria and that maneuvers thattubular cells from the underlying basement membrane.
Presumably, infiltration of the amorphous material dis- reduce proteinuria also retard progression are often cited
in support of the hypothesis that filtered proteins damagerupted cell-membrane connections essential for mainte-
nance of normal cell structure [32]. tubules. But these findings could be equally well ac-
counted for by other proposed mechanisms of injury,Kriz et al initially described the extension of adhesions
as causing tubular loss in Fawn hooded and Milan nor- such as tubular obstruction by protein casts or the ten-
dency of glomeruli that leak protein to become scleroticmotensive rats, but also identified this process in other
rodent models [29–31]. We recently observed this form of or form adhesions. The hypothesis that filtered proteins
injure tubular cells has received more direct supportinjury in adriamycin nephrosis [23]. Small tuft-to-capsule
adhesions formed early in the course of nephrosis. Subse- from experiments showing that plasma proteins induce
tubular cell changes in vitro [15, 16, 33–36]. Protein-quently, the adhesions enlarged and amorphous material
spread circumferentially along the capsule beneath a induced changes have included activation of common
stress response systems, elaboration of chemokines, andlayer of fibroblast-like cells. Tubular atrophy leading to
obliteration of the glomerular-tubular connection was apoptosis. Cell culture experiments are necessarily of
short duration, and the protein concentrations used topresent where the amorphous material reached the tubu-
lar neck. One difference between our results and those induce tubular cell changes have been high in some cases.
However, many of the same changes seen in proximalof Kriz et al [29, 30] was that Bowman’s space was usually
not enlarged around glomeruli that had their connections tubule cells exposed to plasma proteins in vitro also have
been observed in proximal tubules of nephrotic animalsto tubules severed by spreading adhesions. Enlargement
of Bowman’s space also has not been observed in studies and humans [37–40]. For example, increased expression
of monocyte chemoattractant protein-1 (MCP-1) has re-of tubular injury induced by nephrotoxins or luminal
obstruction [5, 7, 8]. Thus, the appearance of cystic glo- peatedly been demonstrated in both settings [34, 37, 39,
40]. An increased rate of apoptosis also has been ob-meruli in routine histologic sections probably does not
provide a reliable index of the extent of tubular loss. served in proximal tubules of nephrotic animals and in
tubular cells exposed to plasma proteins in vitro [35, 38].Adhesions between the tuft and capsule also can be hard
to detect on routine sections of renal tissue that has Studies are accumulating rapidly in this area, and their
results are difficult to summarize in a brief review. Innot been perfusion fixed. When carefully looked for,
however, adhesions are observed with remarkable fre- general, however, the in vitro results are consistent with,
although they cannot prove, the hypothesis that filteredquency in animal models of nephrosis. Using the serial
section technique, Rasch et al identified adhesions in proteins cause tubular injury in glomerular disease.
One advantage of the in vitro studies is that they mightmore than 90% of glomeruli following recovery from
a single episode of acute puromycin nephrosis [24]. distinguish which filtered macromolecules are most inju-
rious to tubular cells. Although this question remainsWhether such adhesions expand to cause nephron loss
in the absence of ongoing podocyte injury remains to be unsettled, some studies have indicated that albumin,
while quantitatively the most important filtered protein,determined. The contribution of adhesions to nephron
loss in human glomerular disease also requires further is not the most injurious. In vivo and in vitro evidence
suggests that filtered complement is particularly injuriousstudy. Lesions similar to those observed in Fawn hooded
and Milan rats have been described in a few humans [41]. A further intriguing possibility is that a protein-
bound substance, rather than a filtered protein itself,[30]. However, serial sections did not show that tuft-to-
capsule adhesion and subcapsular accumulation of para- causes injury. Schreiner’s group originally suggested that
an inflammatory lipid is produced when proximal tubuleglomerular material caused tubular loss in the patient
we are discussing today. Of course we need to examine cells metabolize fatty acids carried by filtered albumin
[13]. Harris et al initially suggested that uptake of ironother cases, but this apparent discrepancy brings up a
general problem. The mechanisms of tubular injury that carried by filtered transferrin causes oxidative injury to
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tubular cells [42]. However, the subsequent finding by endocytosed membrane buds off the endosmes in long
the same group that iron depletion does not limit tubular tubular structures [49, 50]. These dense apical tubules
injury associated with proteinuria in the remnant kidney separate from the endosomes and recycle the membrane
model stands against their original hypothesis [43]. Other back to the apical surface of the cell. Kinetic studies
substances, however, are actively under investigation. have shown that the recycling process operates with re-
Interest has focused largely on proteins and protein- markable efficiency and rapidity in the normal tubule.
bound substances, but tubular injury also might be More than 95% of the endocytosed membrane is re-
caused by glomerular leakage of red cells and the resul- turned to the apical surface over a period of less than two
tant exposure of tubular cells to hemoglobin [44]. Hemo- minutes [51]. The time required to degrade endocytosed
globin, like other heme-containing proteins, is a potent proteins, however, is longer and varies depending on
cause of tubular cell injury [45]. Nath et al showed that protein structure [52]. It is tempting to speculate that
sustained exposure of tubules to hemoglobin causes tu- accumulation of proteins that are difficult to degrade
bulointerstitial injury similar to that seen in nephrotic causes cell injury, but this remains to be tested.
models [46], and similar injury is seen in some patients Hopefully, maneuvers for blocking proximal tubule
with hemolytic disease [46]. Addis and Oliver routinely endocytosis will soon be devised. This would allow us
quantified excretion of red cells and casts as well as to directly test the hypothesis that protein endocytosis
protein in patients with chronic glomerular disease. In causes tubular injury in glomerular disease and also po-
the patient illustrated in Figure 1, for example, they tentially provide us with a means for preventing such
documented excretion of more than 7 million red cells/ injury. Recent studies have identified important molecu-
day and 2 million casts/day as well as 7 g of protein/day lar mechanisms of proximal tubule endocytosis that are
[10]. It is possible that tubular obstruction and hematuria potential targets for therapeutic manipulation. The first
would be more often considered as contributors to pro- step in endocytosis is receptor binding. Remarkably, only
gression if such measurements still were made. two receptors bind the whole variety of substances now
The mechanism by which uptake of heme proteins known to be taken up by endocytosis from the glomeru-
causes cell injury has been extensively investigated [45]. lar filtrate [53]. One of these is megalin, a member of
It is not so clear how other substances that pass from the LDL receptor family. Most filtered proteins are en-
diseased glomeruli into the tubular lumen can injure docytosed following binding to megalin alone. A smaller
tubular cells. Signaling receptors for specific bioactive number must bind first to cubilin, which was initially
proteins on the apical surface of some tubular segments identified as the receptor for B12-intrinsic factor com-might be activated when increased amounts of proteins plexes in the ileum but subsequently found to be an
such as IGF-1, HGF, or TGF- are filtered from the
endocytic receptor in the proximal tubule. In the case
circulation or produced by damaged glomeruli [47]. In
of these proteins, which include albumin, the protein-vitro experiments have shown that activation of recep-
cubilin complex interacts with megalin to initiate endocy-tors for HGF and TGF- stimulates tubular cell produc-
tosis.tion of inflammatory chemokines. However, signaling
A subsequent step at which endocytosis might provereceptors do not exist on tubular cells for most filtered
subject to manipulation is endosome acidification. Thisproteins. Normally, the tubule takes up only small
process was initially shown to depend on the activity ofamounts of these proteins. But in vitro studies have
the vacuolar H-ATPase [54]. The required parallel ionshown that tubular cells exposed to large amounts of
conductivity is provided by the chloride channel ClC-5,these proteins exhibit potentially injurious changes. One
which co-localizes with H-ATPase in endosomes of thelogical explanation of these findings is that “excessive”
proximal tubule [55, 56]. The ClC-5 gene was initiallyuptake of proteins somehow causes cell injury.
identified as the locus of mutations in patients withTubular uptake of most proteins and protein-bound
Dent’s disease, an X-linked hereditary disorder charac-substances is accomplished by endocytosis [48]. The en-
terized by low-molecular-weight proteinuria and also bydocytic apparatus is most prominent in the proximal
variable hypercalciuria and nephrolithiasis [55, 57]. Re-tubule, and studies of the hypothesis that excessive pro-
cent in vitro studies suggest that both the Na-H ex-tein uptake causes injury have therefore focused on this
changer NHE3 and the vacuolar H-ATPase participatesegment. Endocytic function in normal proximal tubules
in endocytosis. Blockade of the NHE3 prevents albuminhas been beautifully described. Tracer studies have re-
uptake by cultured proximal tubule cells, and exposure ofvealed that filtered proteins bind to the membrane of
these cells to albumin stimulates NHE3 activity (abstract,the coated invaginations, which then pinch off to form
Drumm, J Am Soc Nephrol 12:48A, 2001) [58]. Whyendocytic vesicles [48]. The endocytosed proteins remain
Na-H exchange as well as H pump activity shouldwithin the endocytic vesicles as they coalesce into larger
be required for endocytosis is not understood, but block-endosomes and then fuse with primary lysosomes to form
secondary lysosomes. Meanwhile, the majority of the ade of either process prevents protein endocytosis by
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tubular cells in vitro. Studies of the effect of NHE-3 have been difficult to interpret, in part because these
maneuvers can alter glomerular function [64–67]. Prom-blockade in vivo remain to be performed.
The potential mechanisms of tubular cell injury de- ising results have recently been obtained in the remnant
kidney and other disease models with mycophenolatescribed here (Table 1) are supported by experimental
studies. With the exception of the spread of tuft adhe- mofetil [68]. It is not clear, however, that the beneficial
effects of this agent are due primarily to suppression ofsions, however, their effects cannot be distinguished by
morphologic examination. Moreover, we cannot block inflammation. Genetically altered animals have provided
an important new means for us to study the contributionany of these mechanisms, so we cannot at present assess
their contribution to disease progression. of inflammation to renal dysfunction [63, 69]. A study
of the effect of ureteral obstruction in severe combined
Role of inflammation in tubular injury immunodeficient (SCID) mice lacking mature T-cells pro-
vided dramatic evidence that interstitial inflammatoryAn alternate potential means of slowing progression is
limiting the interstitial changes that regularly accompany cells do not always accelerate injury [69]. As expected,
ureteral obstruction in normal mice caused tubular injurytubular injury. One common feature of interstitial injury
is cellular inflammation [14, 40, 59, 60]. Extensive studies accompanied by an interstitial infiltrate composed of
T-cells and macrophages and by interstitial fibrosis. Fol-have found that the inflammatory infiltrate consists of
T-cells and macrophages both in human and experimen- lowing obstruction in SCID mice, no T-cells accumulated
in the interstitium, but tubular injury, macrophage infil-tal disease. Reviewers of proteinuric renal disease have
regularly proposed that this infiltrate is a target for thera- tration, and interstitial fibrosis proceeded unchecked.
Pharmaceutical agents that block specific molecular me-peutic intervention. Of course it would be best to prevent
the initial glomerular injury, but failing that, it would diators of cellular inflammation are also being developed
rapidly [62]. An example of success with one of thesebe desirable to keep the tubules from being injured by
filtered proteins, either by preventing obstruction, by agents has been provided by another study of ureteral
obstruction in mice, which found that blockade of thelimiting endocytosis, or by some other means. If this
cannot be accomplished, the next best alternative might chemokine receptor CCR-1 prevented infiltration of
T-cells and of macrophages and also limited interstitialbe to limit the inflammation induced by tubular injury.
The suggestion that limiting inflammation is desirable fibrosis in obstructed kidneys [70]. Hopefully, experi-
ments with these new tools will clarify the role of in-presupposes that inflammation is deleterious. At first
glance this supposition might seem so obvious as to be flammation in the progression of proteinuric glomerular
disease.not worth testing. Experimentally, inflammation within
the kidney is most often induced by stimulating the im-
Role of interstitial fibrosismune system to attack some portion of the nephron.
It is not surprising that in such cases the net effect of Along with inflammation, tubular injury in primary
glomerular disease is regularly accompanied by intersti-inflammation is to damage the target. But interstitial
inflammation in proteinuric renal disease presents a dif- tial fibrosis. The possibility that progressive fibrosis
causes tubular loss has prompted widespread interestferent problem. Most studies suggest that in this setting,
injured tubular cells induce inflammation by secreting [14–16, 70, 71]. This interest has been stimulated by mor-
phologic studies showing that the extent of interstitialchemokines and other factors, and not primarily by anti-
gen presentation. The inflammatory infiltrate is thus not fibrosis closely correlates with the degree of renal dys-
function. Again, however, as with inflammation, it isthought to be directed against a specific tubular target.
Infiltrating T-cells and macrophages do have the ability important to distinguish between association and causa-
tion (Fig. 4). Mechanisms by which fibrosis could contrib-to cause tubular injury, and macrophages in particular
produce profibrotic substances [61]. But infiltrating cells ute to tubular loss are easy to imagine. Fibrosis induced
by tubular injury could cause constriction and occlusiondo not always injure, and indeed might help repair, the
tissues in which they accumulate [59, 62, 63]. Without of tubules which, despite injury, would otherwise con-
tinue to function. Spreading fibrosis also could lead toexperimental evidence, it is not clear that the interstitial
infiltrates observed in proteinuric renal disease acceler- destruction of adjacent nephrons, either by constricting
tubules or by depriving them of an adequate capillaryate nephron loss.
Some experimental studies have found that anti- blood supply. Addis and Oliver remarked on the poten-
tial operation of these processes, and believed that “in-inflammatory drugs can limit interstitial injury and pre-
serve renal function even when they do not reduce pro- flammatory scarring” of the interstitium was a major
cause of progressive renal dysfunction in chronic glomer-teinuria [64]. In general, however, a lack of effective
maneuvers to chronically suppress renal interstitial in- ulonephritis [10]. But 70 years later, we have little firm
evidence of the extent to which scarring causes tubularflammation has impeded study of this issue. Results ob-
tained with glucocorticoids and various dietary regimens loss. Morphologic studies have not shown convincingly
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Use of the catch-all term “tubulointerstitial” to describe
all changes outside the glomerulus and arterial tree re-
veals how little we know. Structural features associated
with specific causes of nephron loss have in general not
been identified. In this review, I have assumed that tubu-
lar cell injury precedes interstitial inflammation and fi-
brosis, but even this simple assumption might not be
justified. Glomerular injury could alternatively be trans-
mitted directly to the interstitium by the spread of in-
flammatory mediators through peritubular capillaries or
by destruction of these capillaries [78]. Experiments em-
ploying new means of blocking tubular cell injury, in-
flammation, and fibrosis are eagerly awaited. These ex-
periments should clarify the mechanisms of nephron loss
Fig. 4. Brecon Cathedral graveyard. A nephrologist dissecting this and provide a basis for improved treatment to slow dis-
scene would identify a strong correlation between human remains and ease progression.gravestones, and might be tempted to conclude that people died from
having stones placed over them. [From Cemetery Pictures (http://med-
pharm53.bu.edu/pages/cemeteries.html), used with permission.]
QUESTIONS AND ANSWERS
Dr. Nicolaos E. Madias (Executive Academic Dean,
Tufts University School of Medicine, Boston, Massachu-
that the fibrous reaction around an injured nephron setts): Although the data you presented on serial sec-
causes destruction of its neighbors [72]. However, it is tioning are very convincing regarding the presence of
only recently that this problem has begun to be examined atubular glomeruli, I wonder whether validation has also
in detail. been provided by microdissection studies in experimen-
As in the study of inflammation, the major problem tal studies or human kidneys. Also, is there any informa-
in the study of fibrosis has been the lack of specific tion on the residual blood flow of these atubular glo-
preventive therapies. Progress in identifying the cellular meruli?
and molecular mechanisms responsible for matrix depo- Dr. Meyer: The question is whether there’s been proof
sition in diseased kidneys hopefully will soon make such by microdissection that there are no tubules attached to
therapies possible. The problem, however, is complex. glomeruli that appear atubular in serial sections. Nobody
Inflammatory cells invade the interstitium in response would do the work anymore of microdissecting! And if,
to signals generated by injured tubular cells. Along with like Oliver, you did, you would have trouble proving
the injured tubular cells, these inflammatory cells pro- that the tubules had not “broken off” from your atubular
duce substances that stimulate matrix formation and im- glomeruli. But I think the serial sections are spaced
pair matrix degradation. Resident interstitial fibroblasts, closely enough to convincingly establish that many glo-
pericytes, and transdifferentiating epithelial cells all meruli are atubular.
might participate in matrix production. It remains uncer- The second question is, how much blood flow is still
tain to what extent fibrosis can be limited by manipulat- going through these atubular glomeruli? Drs. Tanner
ing the activity of any one of the myriad signaling mole- and Evan showed that glomerular blood flow was re-
cules that participate in this process. An additional duced but present after single-nephron obstruction [5].
problem is posed by the commonality of the mechanisms Blood flow has not been measured in other models, but
responsible for fibrosis in different settings. It might you see red cells in the capillaries when tissue containing
prove difficult for us to design therapies that limit mal- atubular glomeruli is not perfusion fixed. An interesting
adaptive fibrosis in the kidney without impairing tissue question is what happens over time. That is, do glomeruli
turnover and repair in other organs. To date, the most remain perfused but atubular indefinitely?
promising results have been obtained in the ureteral Dr. Madias: Is there any information on the frequency
obstruction model [73–77]. Success in this model is stimu- of atubular glomeruli in experimental models or clinical
lating extensive efforts to limit interstitial fibrosis in ex- material of predominantly tubulointerstitial diseases as
perimental glomerular disease. compared with glomerular/vascular diseases?
In summary, a great deal remains to be learned about Dr. Meyer: Relatively few studies have been done.
nephron loss in primary glomerular disease. Tubulointer- Dr. Marcussen and his coworkers found atubular glomer-
stitial changes are regularly associated with progressive uli in rats with cis-platinum and lithium nephrotoxicity
reduction of the glomerular filtration rate. But which [7, 8] and in autopsy tissue from patients with diabetic
nephropathy, chronic pyelonephritis, and renal arterychanges cause loss of function remains to be determined.
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stenosis [6]. We have found atubular glomeruli in rats did. Similarly, we can’t identify on morphologic grounds
the cause of the tubular injury that accompanies glomer-with remnant kidneys and with adriamycin nephrosis
[22, 23]. So atubular glomeruli appear both in “tubulo- ular injury in proteinuric patients.
Dr. Dana Miskulin (Division of Nephrology, Newinterstitial” and “glomerular” diseases. In the rat models,
the prevalence of atubular glomeruli is proportional to England Medical Center, Boston, Massachusetts): Let me
ask about the mechanisms by which tubular uptake ofthe reduction in GFR. We have much less information
about the prevalence of atubular glomeruli in human protein could cause tubular injury. Has there been any
study of why increasing the amount of protein taken updisease. And I should again emphasize that we cannot
at present tell by looking at an atubular glomerulus what should injure tubule cells? For example, could release
of lysosomal enzymes or an increased workload causeprocess caused loss of the tubule.
Dr. Madias: You indicated that atubular glomeruli injury?
Dr. Meyer: The question again is, what causes thehave been described in lithium- and platinum-induced
nephrotoxicity. What about acute postischemic renal injury and how can we tell? Lysosomal enzymes are
found in the urine of proteinuric patients. But we can’tfailure?
Dr. Meyer: We have found large numbers of atubular tell whether these enzymes simply leaked following cell
damage or whether they caused the damage. The ideaglomeruli in rats recovering from acute ischemic renal
failure [79, 80]. Presumably, some of the most severely that they leak from overloaded lysosomes into the cyto-
plasm and cause damage, suggested by Thomas Maackdamaged tubules do not recover, although the whole-
kidney GFR returns nearly to normal. Whether glomer- [81], is appealing but unproven. Another suggestion is
that the metabolic work of protein reabsorption coulduli become atubular in acute renal failure in humans is
not known. prove excessive. I think that’s less likely. As you know,
the amount of energy required to absorb sodium, glu-Dr. John T. Harrington (Dean, Tufts University
School of Medicine): I have a question about uremic cose, and bicarbonate is enormous. The amount of pro-
tein that would be reabsorbed, even in a nephrotictoxins, the still mysterious substances that make the pa-
tient feel sick and cause organs to function poorly. You patient, is comparatively modest. Unless protein reab-
sorption somehow consumes energy in a very extrava-raised the issue of uremic toxins damaging renal tubules,
thereby contributing to uremia. Do you have any hypoth- gant way, it’s hard to imagine that it causes a cellular
energy deficit. But clearly we need to learn more aboutesis on what those endogenous toxins might be?
Dr. Meyer: I mistakenly might have implied that ure- the effects of increased reabsorption of filtered proteins
on tubular cells.mic toxins are known to cause tubular injury. I actually
suspect that they cause tubular cell growth. In some Dr. Madias: Of the many proteins that are being fil-
tered, do we know which ones might be injurious to thetubules of failing kidneys, you see cystic overgrowth of
the tubular epithelium which, I imagine, is induced by tubulointerstitium?
Dr. Meyer: Studies in cultured proximal tubule cellsbuildup of the same factors that cause compensatory
renal hypertrophy when you remove one kidney. Those provide a potential means for identifying proteins that
are particularly toxic. Practical limitations of these stud-substances, as you point out, remain to be identified.
Dr. Harrington: Are there specific models in which ies are that high protein concentrations can be required
to produce injury and that experiments are generally ofone can determine a specific tubular response to a spe-
cific toxin? You mentioned that we know how to define limited duration, so that the tubular cell response to
proteins is assessed over hours or days and not weeksvarious glomerular lesions but that we’re not very good
at defining various tubular lesions. Can one distinguish or months. Results obtained to date have been conflict-
ing. For instance, conflicting results have been obtainedtubular lesion A from tubular lesion B or C?
Dr. Meyer: No, and I think this is a major problem as to whether transferrin is more toxic when iron is
attached and whether albumin is less toxic when delipi-in the study of renal disease progression. We distinguish
different types of glomerular injury but generally cannot dated. It’s safe to say that at present, we haven’t clearly
identified culprit proteins.identify types of tubular injury, except perhaps in some
cases of acute renal failure. The problem affects both Dr. Harrington: It seems to me that we’re stuck.
Does the glomerulus or the tubule drop out first? Whatresearch and clinical practice. I work in a hospital with
a large psychiatric population. If we see a patient who kinds of studies would you like to do in your experimen-
tal models to answer that crucial question?has a creatinine of 2 mg/dL and not much proteinuria,
we ask whether that patient ever took lithium. If so, we Dr. Meyer: I would first do additional serial section
studies on human tissue. These studies would quantifytell our trainees that the patient has lithium nephrotoxic-
ity. If the patient took NSAIDs, we suggest a diagnosis of the extent to which tubules atrophy in human proteinuric
renal disease before glomeruli become globally scle-NSAID nephrotoxicity. But we don’t biopsy the patients
and couldn’t identify the cause of tubular injury if we rosed. This would be confirmatory and useful—you’d
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find out to what extent tubules are gone when glomerular proteinuria and slow disease progression. Solid evidence
indicates that the magnitude of proteinuria and the ratecapillary surface still was available for filtration. You’d
also find out to what extent tubular loss is related to of disease progression are related. As long as this patient
only had 1 or 2 protein on dipstick, he received onlyocclusion—choking—of the tubular neck by material ex-
tending from tuft adhesions. I think further morphologic antihypertensive medication, including ACE inhibitors.
When the protein excretion rose to nephrotic levels, thestudies in animal models might reveal differences be-
tween tubular injury caused by obstruction, ischemia, treating physicians felt compelled to try further measures
to limit it. There is evidence in animal models that rever-and endocytosis of filtered substances. In short, if we
looked harder at the tissue, we might get a better idea sal of some features of glomerular segmental sclerosis is
possible [82]. But it seems very unlikely that function isof what is destroying the tubules. But what we are really
waiting for is an experimental means of interrupting the ever restored in atubular glomeruli.
Dr. Bertrand L. Jaber (Division of Nephrology, Newputative processes of tubular injury. For example, if en-
docytosis of filtered proteins causes injury, blocking England Medical Center): What is the role of apoptotic
stimuli in the progression of renal disease following tubu-endocytosis should slow tubular injury. The endocytic
receptor protein megalin has been knocked out, but un- lar injury by protein trafficking, and specifically, the role
of the Fas/Fas ligand system in mediating these events?fortunately the knockout mice have brain defects and
grow poorly. There are dogs that do not express cubilin in Dr. Meyer: Apoptosis is increased in tubular cells
exposed to protein in vitro and in proximal tubules ofthe brush border and therefore do not reabsorb filtered
albumin, and I expect that somebody will study renal proteinuric animals. Both mitosis and apoptosis are in-
creased in proximal tubules when heavy proteinuria isdisease progression in these animals. From such studies,
we’re eventually going to find out which mechanisms present, that is, cell turnover is increased. I cannot com-
ment specifically on the role of the Fas/Fas ligand systemcontribute most to tubular injury.
Dr. Harrington: This patient was treated with cyclo- in these events. But a more general question is, can you
reduce injury by interfering with apoptosis? It seemssporine on several occasions. Was this done out of des-
peration because we don’t have anything better? Are possible that apoptosis is triggered only when the cells
are severely injured, and that attempts to manipulatethere well-controlled trials of cyclosporine in patients
with FSGS? apoptotic signals thus might not preserve tubules.
Dr. David Cahan (Faulkner Hospital, Boston, Massa-Dr. Meyer: The patient was diagnosed as having focal
and segmental glomerulosclerosis which, as you know, chusetts): Do you think it’s likely that this man had pri-
mary tubular disease 20 years ago and subsequently de-is not a disease but a morphologic description. Several
studies have suggested that in FSGS, cyclosporine lowers veloped heavy proteinuria that we attribute to primary
glomerular disease?proteinuria and can slow loss of renal function. Unfortu-
nately, proteinuria often decreases during treatment only Dr. Meyer: It certainly seems possible. But I should
point out that the first biopsy obtained in this patientto rebound after cyclosporine is stopped, as it initially
did in the present case. An interesting question is, which did not show widespread tubular injury. So the putative
initial tubular injury, if it occurred, was presumably focal.cases of focal glomerular sclerosis will respond to cyclo-
sporine? The patient we are discussing had a somewhat Dr. Cahan: I used to believe that if someone had
heavy proteinuria and had been taking lithium, weunusual history, in that protein was detected in his urine
for more than a decade before it increased to “nephrotic” should consider diseases other than lithium nephropathy.
The data out now indicate that people with chronic lith-levels. I don’t think the published studies tell us whether
we would expect a beneficial response to cyclosporine ium nephropathy can develop heavy proteinuria. This
might be another example of the evolution of tubularwith this clinical history.
Another interesting question that I didn’t address is disease.
Dr. Meyer: There are also cases, as you know, ofwhether cyclosporine itself caused some of the tubular
injury present in the second biopsy. That is, did cyclospo- pyelonephritis due to tuberculosis, of reflux nephropa-
thy, and of NSAID-related nephropathy in which heavyrine reduce the arteriolar supply to some nephrons, and
did these nephrons then suffer glomerular shrinkage and proteinuria and focal sclerosis occur. In rats, most forms
of tubular injury cause secondary focal sclerosis, includ-tubular atrophy? Again, when more than one process is
active, we usually cannot tell which one caused nephron ing injury induced by acute radiation exposure and acute
ischemia. I think we have to be somewhat careful withloss.
Dr. Harrington: This gentleman had disease for 17 the human lithium and NSAID cases, because it’s guilt
by association. That is, no morphologic findings haveyears. Could you reverse his disease that many years
later? That seems bizarre to me. established that the original injury was initiated by these
commonly used drugs. In today’s patient, it’s intriguingDr. Meyer: I think the physicians treating this patient
were not hoping to reverse his disease but to reduce the to wonder whether his renal disease was initiated by a
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reflux in infancy that we are not aware of, or even by not return in some nephrons [86]. Our morphologic stud-
some kind of infection. The question can be expressed, ies suggest that the nephrons in which function does not
what causes the cases of focal sclerosis that don’t start return become atubular [79, 80].
as sudden massive nephrosis and aren’t characterized Dr. Khan: Can tubules regenerate if the glomerulus
as early recurrence after transplantation, for example, remains perfused?
FSGS that doesn’t appear to be caused by some circulat- Dr. Meyer: My guess is that function is lost forever
ing factor? in the glomeruli we identify as atubular, and that their
Dr. Madias: Could you please expand a bit more on tubules can’t grow back. In these glomeruli, I think the
the pathogenesis of the adhesion formation observed in scaffold for tubular regeneration is gone. That is, the
atubular glomeruli? What do you think the role of the connection of the capsular basement membrane to the
target cell is in this process? tubular basement membrane is broken, and the shrunken
Dr. Meyer: Attention has only recently been focused glomerulus is sealed off by fibrosis.
on the adhesions. One possibility is that glomerular base- Dr. Madias: This is bad news for the concept of regres-
ment membrane that has been left bare when podocytes sion of glomerulosclerosis.
are injured “sticks” to Bowman’s capsule and triggers a Dr. Meyer: When proteinuria remits, people are
cellular response. Dr. Kriz and his coworkers recently seeing some evidence of reduction in the amount of
showed that altered podocytes can themselves form a interstitial expansion and some reduction in the extent
bridge between the tuft and the capsule [83]. Dr. Ruth of glomerular segmental scarring. Presumably, the re-
Rasch and I studied puromycin nephropathy and found gression of glomerular changes could improve function
that after a single episode of acute nephrosis, 90% of in glomeruli that are still connected to tubules. Regres-
the glomeruli exhibit parietal to tuft adhesions [24]. We sion of interstitial changes might be associated with re-
hypothesized that during acute nephrosis, the parietal generation of epithelium in atrophic tubules, but I think
cells become activated and grow into the tuft. The diffi- this remains to be demonstrated.
culty with these studies is that we have still pictures
instead of movies. And when you see an altered cell in ACKNOWLEDGMENTS
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